Weight-loss drug reduces risk of early death for patients with heart failure, trial finds 0 21.11.2024 03:31 Sciencedaily.com Weight-loss and diabetes drug tirzepatide can reduce the risk of death or worsening heart failure for patients with obesity and heart failure with preserved pump function, new research reveals. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
